Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population
- Conditions
- Asthma
- Registration Number
- NCT02153411
- Lead Sponsor
- AstraZeneca
- Brief Summary
Descriptive study on the management of asthma in asthmatic Middle East adult population : Algeria,Egypt, Irak,Iran, Jordan, Koweit, Lebanon, Qatar,Saudi,Tunisia, UAE
- Detailed Description
Multicentric, transversal, descriptive, epidemiological study, conducted in a random sample of general practitioner and medical specialist (Pulmonologist and/or allergologist) in the public and the private sector.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7294
Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained.
- Patient concurrently participating to another study. Patient with concomitant pulmonary disease. Patient with psychiatric disorders. Patient consulting for an asthma attack
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Asthma control Up to 1 year Daytime symptoms Limitation of activities Nocturnal symptoms / awakening Need for reliever /rescue treatment Lung function (PEF or FEV)
- Secondary Outcome Measures
Name Time Method asthma control level Up to 4 weeks Asthma control test questionnaire : activities at work,breathless,asthma symptoms (wheezing, coughing, chest tightness, shortness of breath;use of rescue inhaler or taken a nebulizer treatment ,asthma assessment
general and sociodemographic patient's characteristics up to 1 year sex, age, BMI, educational level, occupation, comorbidities, smoking status, and social security coverage.
Identify predictive factors of asthma control, UP to 1 year such as age, sex, BMI, smoking status, adherence to treatment, asthma history, comorbidity.
Trial Locations
- Locations (1)
Research Site
🇦🇪Sharjah, Nis-rme-xxx-2014/1, United Arab Emirates